RxSight, Inc. ($RXST)
Filing Information
| Accession Number | 0001193125-26-386837 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 10, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
849,599
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Stock option (right to buy) | Derivative | Sep 5, 2026 | Sale to Issuer | 98,367 | โ | โ | 0 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Sale to Issuer | 120,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Sale to Issuer | 92,200 | โ | โ | 0 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Sale to Issuer | 50,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Sale to Issuer | 125,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Grant/Award | 73,960 | โ | โ | 73,960 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Grant/Award | 104,347 | โ | โ | 104,347 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Grant/Award | 59,483 | โ | โ | 59,483 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Grant/Award | 32,258 | โ | โ | 32,258 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Grant/Award | 93,984 | โ | โ | 93,984 | Direct | โ | View Details |